{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:27:01Z","timestamp":1791192421679,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1097\/ftd.0000000000000071","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T11:53:05Z","timestamp":1396353185000},"page":"656-662","source":"Crossref","is-referenced-by-count":11,"title":["Impact of Clinical Decision Support Guidelines on Therapeutic Drug Monitoring of Gentamicin in Newborns"],"prefix":"10.1097","volume":"36","author":[{"given":"Caroline","family":"Fonzo-Christe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Guignard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Zaugg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Coehlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara M.","family":"Posfay-Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Gervaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Desmeules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Rollason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Combescure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regula","family":"Corbelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rimensberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Bonnabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210129","doi-asserted-by":"crossref","first-page":"F4","DOI":"10.1136\/adc.2009.178483","article-title":"Heath PT, et al..","volume":"96","author":"Muller-Pebody","year":"2011","journal-title":"Empirical treatment of neonatal sepsis are the current guidelines adequate Arch Dis Child Fetal Neonatal Ed"},{"key":"R2-15-20210129","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ebch.747","article-title":". One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev. 2011;(11):CD005091. Published in Evid.","volume":"6","author":"Rao","year":"2011","journal-title":"-Based Child Health"},{"key":"R3-15-20210129","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":". Developmental pharmacology drug disposition, action, and therapy in infants and children.","volume":"349","author":"Kearns","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-15-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1651-2227.1983.tb09852.x","article-title":"Water distribution in the foetus and newborn infant.","volume":"305","author":"Friis-Hansen","year":"1983","journal-title":"Acta Paediatr Scand Suppl"},{"key":"R5-15-20210129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1084-2756(03)00043-5","article-title":"Clinical implications of postnatal alterations in body water distribution.","volume":"8","author":"Modi","year":"2003","journal-title":"Semin Neonatol"},{"key":"R6-15-20210129","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2146\/ajhp040555","article-title":"Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy.","volume":"62","author":"Bond","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"R7-15-20210129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007691-199902000-00010","article-title":"NA, Mathot RA, Geus WP, et al.. Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis.","volume":"21","year":"1999","journal-title":"Ther Drug Monit"},{"key":"R8-15-20210129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1592\/phco.21.5.443.34490","article-title":". Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs.","volume":"21","author":"Streetman","year":"2001","journal-title":"Pharmacotherapy"},{"key":"R9-15-20210129","first-page":"83","article-title":". Cost-effectiveness of therapeutic drug monitoring: an update.","volume":"13","author":"Touw","year":"2007","journal-title":"EJHP Sci"},{"key":"R10-15-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.blre.2010.08.001","article-title":"Anaemia of prematurity: pathophysiology and treatment.","volume":"24","author":"Strauss","year":"2010","journal-title":"Blood Rev"},{"key":"R11-15-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/clinchem\/43.1.222","article-title":"Therapeutic drug monitoring principles in the neonate. National Academy of Clinical Biochemistry.","volume":"43","author":"Koren","year":"1997","journal-title":"Clin Chem"},{"key":"R12-15-20210129","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/clinchem\/44.2.401","article-title":". Strategies for physician education in therapeutic drug monitoring.","volume":"44","author":"Bates","year":"1998","journal-title":"Clin Chem"},{"issue":"suppl 1","key":"R13-15-20210129","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1111\/j.1365-2125.2001.00770.x","article-title":"Best practice in therapeutic drug monitoring.","volume":"52","author":"Gross","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"R14-15-20210129","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11096-012-9614-6","article-title":". Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring.","volume":"34","author":"Swartling","year":"2012","journal-title":"Int J Clin Pharm"},{"key":"R15-15-20210129","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/adc.2007.137026","article-title":". A simplified gentamicin dosing chart is quicker and more accurate for nurse verification than the BNFc.","volume":"94","author":"Wong","year":"2009","journal-title":"Arch Dis Child"},{"key":"R16-15-20210129","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1592\/phco.23.5.585.32196","article-title":". A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates.","volume":"23","author":"DiCenzo","year":"2003","journal-title":"Pharmacotherapy"},{"key":"R17-15-20210129","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00007691-200208000-00011","article-title":". Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates.","volume":"24","author":"Stolk","year":"2002","journal-title":"Ther Drug Monit"},{"key":"R18-15-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2146\/ajhp090661","article-title":". Effects of therapeutic drug monitoring criteria in a computerized prescriber-order-entry system on the appropriateness of vancomycin level orders.","volume":"68","author":"Traugott","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"R19-15-20210129","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2146\/ajhp100155","article-title":". Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin.","volume":"68","author":"Cox","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"R23-15-20210129","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/ajhp\/62.8.823","article-title":"Prediction of gentamicin peak and trough concentrations from six extended-interval dosing protocols for neonates.","volume":"62","author":"Murphy","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"R24-15-20210129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2146\/ajhp100114","article-title":". Comparative evaluation of six extended-interval gentamicin dosing regimens in premature and full-term neonates.","volume":"68","author":"Fullas","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"R25-15-20210129","first-page":"1100","article-title":"Penford G, et al..","volume":"98","author":"Serane","year":"2009","journal-title":"Once daily dose gentamicin in neonates: is our dosing correct Acta Paediatr"},{"key":"R26-15-20210129","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.jp.7210996","article-title":". Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels.","volume":"23","author":"Hansen","year":"2003","journal-title":"J Perinatol"},{"key":"R27-15-20210129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11096-008-9255-y","article-title":"Pharmacological differences between once daily and twice daily gentamicin dosage in newborns with suspected sepsis.","volume":"31","author":"Hagen","year":"2009","journal-title":"Pharm World Sci"},{"key":"R28-15-20210129","first-page":"264","article-title":"Accuracy of empiric gentamicin dosing guidelines in neonates.","volume":"15","author":"Hitron","year":"2010","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R29-15-20210129","doi-asserted-by":"crossref","first-page":"F487","DOI":"10.1136\/archdischild-2012-302261","article-title":". Neonatal sepsis: many blood samples, few positive cultures: implications for improving antibiotic prescribing.","volume":"97","author":"Blackburn","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R30-15-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00007691-200202000-00002","article-title":". Potential benefit of Bayesian forecasting for therapeutic drug monitoring in neonates.","volume":"24","author":"Pons","year":"2002","journal-title":"Ther Drug Monit"},{"key":"R31-15-20210129","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1136\/bmjqs-2012-000824","article-title":". Using six sigma to improve once daily gentamicin dosing and therapeutic drug monitoring performance.","volume":"21","author":"Egan","year":"2012","journal-title":"BMJ Qual Saf"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T14:42:38Z","timestamp":1716648158000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201410000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000071","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}